Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Häufige urologisch-sexualmedizinische Themen in der Praxis sind das Thema des MMW-Webinars am 5. Juni von 17.30 bis 19 Uhr. Konkret geht es um die Frage, wann bei Harnwegsinfektionen auf Antibiotika verzichtet werden kann, und um ein Update zur Therapie von Libido- und Potenzstörungen des Mannes. Der dritte Vortrag behandelt sexuell übertragbare Krankheiten. Stellen Sie Ihre Fragen an die Experten und sammeln Sie 2 CME-Punkte. Jetzt gleich anmelden!
Erweiterte Suche
Anmelden
nach oben
Administration and Policy in Mental Health and Mental Health Services Research
Erschienen in: Administration and Policy in Mental Health and Mental Health Services Research 2/2017

10.02.2016 | Original Article

Fostering Psychotropic Medication Oversight for Children in Foster Care: A National Examination of States’ Monitoring Mechanisms

verfasst von: Thomas I. Mackie, Justeen Hyde, Lawrence A. Palinkas, Emily Niemi, Laurel K. Leslie

Erschienen in: Administration and Policy in Mental Health and Mental Health Services Research | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

To describe state responses to psychotropic medication safety concerns among children in foster care, this study proposes a taxonomy for state-level psychotropic medication monitoring mechanisms and highlights state variations. Seventy-two key informants, representing state child-serving agencies within the 50 states and DC, completed semi-structured interviews. We employed modified grounded theory to develop the taxonomy, and then generated state-specific summaries that were validated by key informants. Nationally, 88.2 % of the states employed at least one of seven mechanisms. For the most frequently implemented mechanisms (collegial secondary review, prior authorization, database review), over half were implemented between January 2011 and July 2013.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
Adams, A. S., Zhang, F., LeCates, R. F., Graves, A. J., Ross-Degnan, D., Gilden, D., & Soumerai, S. B. (2009). Prior authorization for antidepressants in Medicaid: effects among disabled dual enrollees. Archives of Internal Medicine, 169(8), 750.CrossRefPubMedPubMedCentral
Battistelli, E. S. (1996). Making managed health care work for kids in foster care: A guide to purchasing services. Washington, DC: CWLA Press.
Berwick, D. M., Nolan, T. W., & Whittington, J. (2008). The triple aim: Care, health, and cost. Health Affairs, 27(3), 759–769.CrossRefPubMed
Blee, K. (2004). Evaluating qualitative research. Washington, DC: National Science Foundation.
Child and Family Services Improvement and Innovation Act, Pub. L. No. 112-34, 42 U.S.C. § 1305 C.F.R. (2011).
Comer, J. S., Olfson, M., & Mojtabai, R. (2010). National trends in child and adolescent psychotropic polypharmacy in office-based practice, 1996–2007. Journal of the American Academy of Child and Adolescent Psychiatry, 49(10), 1001–1010.CrossRefPubMedPubMedCentral
Constantine, R., & Tandon, R. (2008). Changing trends in pediatric antipsychotic use in Florida’s Medicaid program. [Research Support, Non-U.S. Gov’t]. Psychiatric Services, 59(10), 1162–1168.CrossRefPubMed
Cooper, W. O., Hickson, G. B., Fuchs, C., Arbogast, P. G., & Ray, W. A. (2004). New users of antipsychotic medications among children enrolled in TennCare. Archives of Pediatrics and Adolescent Medicine, 158(8), 753–759.CrossRefPubMed
Correll, C. U. (2008). Monitoring and management of antipsychotic-related metabolic and endocrine adverse events in pediatric patients. International Review of Psychiatry, 20(2), 195–201.CrossRefPubMed
Correll, C. U., Kratochvil, C. J., & March, J. S. (2011). Developments in pediatric psychopharmacology: Focus on stimulants, antidepressants, and antipsychotics. Journal of Clinical Psychiatry, 72, 650–670.
Costello, E., Costello, A., Edelbrock, C., Burns, B., Dulcan, M., Brent, D., & Janiszewski, S. (1988). Psychiatric disorders in pediatric primary care: Prevalence and risk factors. Archives of General Psychiatry, 45(12), 1107.CrossRefPubMed
Crystal, S., Olfson, M., Huang, C., Pincus, H., & Gerhard, T. (2009). Broadened use of atypical antipsychotics: safety, effectiveness, and policy challenges. Health Affairs (Millwood), 28(5), w770–w781.CrossRef
dosReis, S., Zito, J. M., Safer, D. J., Gardner, J. F., Puccia, K. B., & Owens, P. L. (2005). Multiple psychotropic medication use for youths: A two-state comparison. Journal of Child and Adolescent Psychopharmacology, 15(1), 68–77.CrossRefPubMed
dosReis, S., Zito, J. M., Safer, D. J., & Soeken, K. L. (2001). Mental health services for youths in foster care and disabled youths. American Journal of Public Health, 91(7), 1094–1099.CrossRefPubMedPubMedCentral
Esposito, D., & Verdier, J. M. (2009). An assessment of the impact of an educational pharmacy management intervention on prescribers to medicaid beneficiaries. Chicago, IL: Mathematica Policy Research Inc.
Ferguson, D. G., Glesener, D. C., & Raschick, M. (2006). Psychotropic drug use with European American and American Indian children in foster care. Journal of Child and Adolescent Psychopharmacology, 16(4), 474–481.CrossRefPubMed
Fostering Connections to Success and Increasing Adoptions Act of 2008, Pub. L. No. 110-351, 42 U.S.C. § 1305 C.F.R. (2008).
GAO. (2012). Children’s mental health: Concerns remain about appropriate services for children in medicaid and foster care (pp. 13–15). Washington DC: United States Government Accountability Office.
GAO. (2014). Foster Children: HHS Could Provide Additional Guidance to States Regarding Psychotropic Medications. Washington, D.C.
Garland, A. F., Hough, R. L., Landsverk, J. A., & Brown, S. A. (2001). Multi-sector complexity of systems of care for youth with mental health needs. Children’s Services: Social Policy, Research, & Practice, 4(3), 123–140.CrossRef
Geen, R. (2009). The Fostering connections to success and increasing adoptions act: Implementation issues and a look ahead at additional child welfare reform (pp. 1–17). Child Trends: Bethesda.
Glisson, C., & Hemmelgarn, A. (1998). The effects of organizational climate and interorganizational coordination on the quality and outcomes of children’s service systems. [Research Support, U.S. Gov’t, P.H.S.]. Child Abuse and Neglect, 22(5), 401–421.CrossRefPubMed
Government Accountability Office (GAO). (2011). Foster Children HHS guidance could help states improve oversight of psychotropic prescriptions (GAO-12-270T). Washington, DC: United States Government Accountability Office.
Grimshaw, J. M., Shirran, L., Thomas, R., Mowatt, G., Fraser, C., Bero, L., & O’Brien, M. A. (2001). Changing provider behavior: An overview of systematic reviews of interventions. Medical Care, 39, II2–II45.CrossRefPubMed
Holahan, J., Well, A., & Wiener, J.M. (2003). Which way for federalism and health policy? Health Aff (Millwood), Suppl Web Exclusives, W3-317-333.
Huefner, J. C., & Griffith, A. K. (2014). Psychotropic medication use with troubled children and youth. Journal of Child and Family Studies, 23, 613–616.CrossRef
Hurlburt, M. S., Leslie, L. K., Landsverk, J., Barth, R. P., Burns, B. J., Gibbons, R. D., & Zhang, J. (2004). Contextual predictors of mental health service use among children open to child welfare. Archives of General Psychiatry, 61(12), 1217.CrossRefPubMedPubMedCentral
Jensen, P., Buitelaar, J., Pandina, G., Binder, C., & Haas, M. (2007). Management of psychiatric disorders in children and adolescents with atypical antipsychotics. European Child and Adolescent Psychiatry, 16(2), 104–120.CrossRefPubMed
Kiefe, C. I., Allison, J. J., Williams, O. D., Person, S. D., Weaver, M. T., & Weissman, N. W. (2001). Improving quality improvement using achievable benchmarks for physician feedback: a randomized controlled trial. JAMA, 285(22), 2871–2879.CrossRefPubMed
Lakhan, S. E., & Hagger-Johnson, G. E. (2007). The impact of prescribed psychotropics on youth. Clinical Practice and Epidemiology in Mental Health, 3(1), 21.CrossRefPubMedPubMedCentral
Landsverk, J., Garland, A. F., & Leslie, L. K. (2002). Mental health services for children reported to child protective services. In K. J. Saywitt, G. S. Goodman, & T. D. Lyon (Eds.), The APSAC handbook on child maltreatment (Vol. 2nd, pp. 487–507). Thousand Oaks, CA: Sage Publications Inc.
Law, M., Ross-Degnan, D., & Soumerai, S. (2008). Effect of prior authorization of second-generation antipsychotic agents on pharmacy utilization and reimbursements. Psychiatric Services, 59(5), 540–546.CrossRefPubMed
Leslie, L. K., Kelleher, K. J., Burns, B. J., Landsverk, J., & Rolls, J. A. (2003). Foster care and Medicaid managed care. [Review]. Child Welfare, 82(3), 367–392.PubMed
Leslie, L.K., Mackie, T.I., Dawson, E.H., Bellonci, C., Schoonover, D.R., Rodday, A.M., et al. (2010). Multi-state study on psychotropic medication oversight in foster care. Study report and appendix. Boston, MA: Tufts University Clinical and Translational Science Institute.
Lu, C. Y., Adams, A. S., Ross-Degnan, D., Zhang, F., Zhang, Y., Salzman, C., & Soumerai, S. B. (2011). Association between prior authorization for psychiatric medications and use of health services among medicaid patients with bipolar disorder. Psychiatric Services (Washington, DC), 62(2), 186.CrossRef
Mackie, T. I., Hyde, J., Rodday, A. M., Dawson, E., Lakshmikanthan, R., Bellonci, C., et al. (2011). Psychotropic medication oversight for youth in foster care: A national perspective on state child welfare policy and practice guidelines. Children and Youth Services Review, 33(11), 2213–2220.CrossRef
Mackie, T. I., Mulé, C. M., Hyde, J., & Leslie, L. K. (2013). Mental health oversight for children and adolescents in child welfare custody. In A. Powell & J. Gray-Peterson (Eds.), Child welfare: Current issues, practices and challenges. Hauppauge, NY: Nova Science Publishers Inc.
Matone, M., Localio, R., Huang, Y. S., dosReis, S., Feudtner, C., & Rubin, D. (2012). The relationship between mental health diagnosis and treatment with second-generation antipsychotics over time: A national study of U.S. Medicaid-enrolled children. Health Services Research, 47(5), 1836–1860.CrossRefPubMedPubMedCentral
Miles, M. B., & Huberman, A. M. (1994). Qualitative data analysis: An expanded sourcebook (Vol. 2). Thousand Oaks, CA: Sage.
National Committee on Quality Assurance (NCQA). (2014). Proposed new Measures for HEDIS 2015: Safe and Judicious Antipsychotic Use in Children and Adolescents. Washington D.C.
Navarro, R. (2009). Managed care pharmacy practice. Sudbury, MA: Jones & Bartlett Learning.
Naylor, M. W., Davidson, C. V., Ortega-Piron, D. J., Bass, A., Gutierrez, A., & Hall, A. (2007). Psychotropic medication management for youth in state care: Consent, oversight, and policy considerations. Child Welfare, 86(5), 175.PubMed
Nevels, R. M., Dehon, E. E., Alexander, K., & Gontkovsky, S. T. (2010). Psychopharmacology of aggression in children and adolescents with primary neuropsychiatric disorders: A review of current and potentially promising treatment options. Experimental and Clinical Psychopharmacology, 18(2), 184–201.CrossRefPubMed
Noonan, K., Miller, D. (2013). Fostering transparency: A preliminary review of policy governing psychotropic medications in foster care. Hastings Law Journal, 65, 1515.
Olfson, M., Blanco, C., Liu, L. X., Moreno, C., & Laje, G. (2006). National trends in the outpatient treatment of children and adolescents with antipsychotic drugs. Archives of General Psychiatry, 63(6), 679–685.CrossRefPubMed
Olfson, M., Marcus, S. C., Weissman, M. M., & Jensen, P. S. (2002). National trends in the use of psychotropic medications by children. Journal of the American Academy of Child and Adolescent Psychiatry, 41(5), 514–521.CrossRefPubMed
Palinkas, L. A., Horwitz, S. M., Chamberlain, P., Hurlburt, M. S., & Landsverk, J. (2011). Mixed-methods designs in mental health services research: A review. Psychiatric Services, 62(3), 255–263.CrossRefPubMed
Peterson, A., Chan, V., & Wilson, M. D. (1999). Drug utilization review strategies. In R. Navarro (Ed.), Managed care pharmacy practice (pp. 215–231). Sudbury, MA: Jones and Bartlett Publishers.
Romanelli, L. H., Landsverk, J., Levitt, J. M., Leslie, L. K., Hurley, M. M., Bellonci, C., et al. (2009). Best practices for mental health in child welfare: Screening, assessment, and treatment guidelines. [Consensus Development Conference Practice Guideline]. Child Welfare, 88(1), 163–188.PubMed
Rubin, D., Matone, M., Huang, Y. S., dosReis, S., Feudtner, C., & Localio, R. (2012). Interstate variation in trends of psychotropic medication use among Medicaid-enrolled children in foster care. Children and Youth Services Review, 34(8), 1492–1499.CrossRef
Safer, D. J., Zito, J. M., & dosReis, S. (2003). Concomitant psychotropic medication for youths. American Journal of Psychiatry, 160(3), 438–449.CrossRefPubMed
Schmid, I., Burcu, M., & Zito, J. M. (2015). Medicaid prior authorization policies for pediatric use of antipsychotic medications. JAMA, 313(9), 966–968.CrossRefPubMed
Stein, B. D., Leckman-Westin, E., Okeke, E., Scharf, D. M., Sorbero, M., Chen, Q., & Wisdom, J. P. (2014). The effects of prior authorization policies on Medicaid-enrolled children’s use of antipsychotic medications: evidence from two Mid-Atlantic states. Journal of child and adolescent psychopharmacology, 24(7), 374–381.CrossRefPubMedPubMedCentral
Swanson, J., Arnold, L. E., Kraemer, H., Hechtman, L., Molina, B., Hinshaw, S., et al. (2008). Evidence, interpretation, and qualification from multiple reports of long-term outcomes in the Multimodal Treatment study of Children With ADHD (MTA): Part I: Executive summary. Journal of Attention Disorders, 12(1), 4–14.CrossRefPubMed
Thompson, J. N., Varley, C. K., McClellan, J., Hilt, R., Lee, T., Kwan, A. C., & Trupin, E. (2009). Second opinions improve ADHD prescribing in a Medicaid-insured community population. Journal of the American Academy of Child and Adolescent Psychiatry, 48(7), 740–748.CrossRefPubMed
Vitiello, B. (2007). Research in child and adolescent psychopharmacology: Recent accomplishments and new challenges. Psychopharmacology (Berl), 191(1), 5–13.CrossRef
Vitiello, B., Correll, C., van Zwieten-Boot, B., Zuddas, A., Parellada, M., & Arango, C. (2009). Antipsychotics in children and adolescents: increasing use, evidence for efficacy and safety concerns. European Neuropsychopharmacology, 19(9), 629–635.CrossRefPubMed
Willms, D. G., Best, J. A., Taylor, D. W., Gilbert, J. R., Wilson, D. M. C., Lindsay, E. A., & Singer, J. (1990). A systematic approach for using qualitative methods in primary prevention research. Med Anthro Q, 4(4), 391–409.CrossRef
Zito, J. M., Safer, D. J., Sai, D., Gardner, J. F., Thomas, D., Coombes, P., et al. (2008). Psychotropic medication patterns among youth in foster care. Pediatrics, 121(1), e157–e163.CrossRefPubMed
Metadaten
Titel
Fostering Psychotropic Medication Oversight for Children in Foster Care: A National Examination of States’ Monitoring Mechanisms
verfasst von
Thomas I. Mackie
Justeen Hyde
Lawrence A. Palinkas
Emily Niemi
Laurel K. Leslie
Publikationsdatum
10.02.2016
Verlag
Springer US
Erschienen in
Administration and Policy in Mental Health and Mental Health Services Research / Ausgabe 2/2017
Print ISSN: 0894-587X
Elektronische ISSN: 1573-3289
DOI
https://doi.org/10.1007/s10488-016-0721-x

Weitere Artikel der Ausgabe 2/2017

Administration and Policy in Mental Health and Mental Health Services Research 2/2017 Zur Ausgabe

Original Article

Cardiovascular Disease Mortality of Medicaid Clients with Severe Mental Illness and a Co-occurring Substance Use Disorder

Original Article

Mechanisms of Change in the ARC Organizational Strategy: Increasing Mental Health Clinicians’ EBP Adoption Through Improved Organizational Culture and Capacity

Original Article

Staff Turnover in Assertive Community Treatment (Act) Teams: The Role of Team Climate

Original Article

Building an Evidence Base for Effective Supervision Practices: An Analogue Experiment of Supervision to Increase EBT Fidelity

Original Article

Use of Veterans Health Administration Mental Health and Substance Use Disorder Treatment After Exiting Prison: The Health Care for Reentry Veterans Program

Original Article

Analyzing Long-Duration and High-Frequency Data Using the Time-Varying Effect Model

Neu im Fachgebiet Psychiatrie

Hörschwäche erhöht Demenzrisiko unabhängig von Beta-Amyloid

29.05.2024 Hörstörungen Nachrichten

Hört jemand im Alter schlecht, nimmt das Hirn- und Hippocampusvolumen besonders schnell ab, was auch mit einem beschleunigten kognitiven Abbau einhergeht. Und diese Prozesse scheinen sich unabhängig von der Amyloidablagerung zu ereignen.

So wirken verschiedene Alkoholika auf den Blutdruck

23.05.2024 Störungen durch Alkohol Nachrichten

Je mehr Alkohol Menschen pro Woche trinken, desto mehr steigt ihr Blutdruck, legen Daten aus Dänemark nahe. Ob es dabei auch auf die Art des Alkohols ankommt, wurde ebenfalls untersucht.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise